[1] 王莲, 赵俪梅. 丙型肝炎病毒的母婴传播临床研究进展. 肝脏, 2017,22:638-641.
[2] Bedossa P . Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Why liver biopsy is essential. Liver Int, 2018, 38:64-66.
[3] Pickhardt P J , Malecki K , Hunt O F , et al. Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis. Eur Radiol, 2016, 27:3060-3068.
[5] 中华医学会肝病学分会. 丙型肝炎防治指南(2015年更新版). 中华实验和临床感染病杂志(电子版), 2015, 29:1-19.
[6] Bedossa P , Poynard T . An algorithm for the grading of activity in chronic hepatitis C. Hepatology, 1996, 24:289-293.
[7] 赵连荣, 许德军, 陆忠华, 等. 综合预测模型FibroTest对慢性乙型肝炎肝纤维化的诊断价值. 中国实用内科杂志 2007, 16: 1274-1277.
[8] 杨晴, 刘东屏, 李鲁平,等. 慢性乙型肝炎肝纤维化非创伤性诊断模型的建立与评价. 中华肝脏病杂志, 2017, 25:15-20.
[9] Kim R , Berg, Thomas, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol, 2016, 64:773-780. |
